Pricing Log in Create free account

GridAI Technologies Corp. (GRDX) vs Pelthos Therapeutics Inc. (PTHS)

GridAI Technologies Corp. and Pelthos Therapeutics Inc. are both Biotechnology companies. GridAI Technologies Corp. and Pelthos Therapeutics Inc. are of similar size ($35.6M and $33.3M). GridAI Technologies Corp. has the higher net margin (0.00% vs −199.5%) and the higher return on invested capital (−79.3% vs −82.3%). Across the 13 metrics below, GridAI Technologies Corp. leads on 8 and Pelthos Therapeutics Inc. on 5.

Valuation

Metric GRDX PTHS Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.78 9.40
P/B 2.07 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1.88 9.02
Earnings yield (113.82%) (276.23%) (32.88%)
Free cash flow yield (26.34%) (126.55%) (23.13%)

Profitability

Metric GRDX PTHS Biotechnology median
Gross margin 0.00% 78.59% 68.51%
Operating margin 0.00% (133.42%) 0.00%
Net margin 0.00% (199.50%) 0.00%
Free cash flow margin 0.00% (98.37%) 0.00%
Return on equity (485.88%) 2,161.07% (51.96%)
Return on assets (34.14%) (125.04%) (46.06%)
Return on invested capital (79.29%) (82.34%) 0.00%

Growth

Metric GRDX PTHS Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 74.65% (61.12%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric GRDX PTHS Biotechnology median
Debt to equity 0.01 (46.58) 0.00
Current ratio 0.16 1.98 4.97
Net debt to EBITDA 0.10 (0.45) 1.01

Dividend

Metric GRDX PTHS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GRDX PTHS Biotechnology median
Market cap 33.30m 35.61m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack